nash tirzepatide Effect of versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 Tirzepatide made headlines for weight

To evaluate the effect of the ...

GLP-1 RAs have demonstrated benefits in coronary artery disease, heart failure, blood pressure, and atrial fibrillation irrespective of type 2 diabetes mellitus status, with new possible applications in peripheral arterial disease

Reddys Laboratories has launched Obeda, an injectable semaglutide therapy for diabetes and weight management in India.

This pro-grade device combines Amber/Yellow, Red, and Infrared wavelengths to support deeper tissue repair and circulation

What we all do impacts those around us

While most people associate GLP-1 with weight-loss injections, this system goes far beyond that